Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity

Fig. 2

(A) platelet (PLT), (B) plateletcrit (PCT), (C) platelet-to-albumin ratio (PLT/ALB), (D) fibrinogen (FIB), (E) high sensitive C-reactive protein (hs-CRP), and (F) erythrocyte sedimentation rate (ESR) serum concentration differences between low endoscopic Crohn’s disease (CD) activity (SES-CD < 10) and high endoscopic CD activity (SES-CD ≥ 10) in patients with CD.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us